Nevertheless, HNSCC patients with high NET-scores appeared to have a higher trend of TP53 mutations as compared to patients with low NET-scores, i.e., 71% vs. 63%, respectively (Figures 4A, B). Here, TP53 is linked to head and neck squamous cell carcinoma.